TLR9 expression in chronic lymphocytic leukemia identifies a promigratory subpopulation and novel therapeutic target. (2021)

First Author: Kennedy E
Attributed to:  Overcoming Ibrutinib and Venetoclax resistance in Chronic Lymphocytic Leukaemia. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1182/blood.2020005964

PubMed Identifier: 33512408

Publication URI: http://europepmc.org/abstract/MED/33512408

Type: Journal Article/Review

Volume: 137

Parent Publication: Blood

Issue: 22

ISSN: 0006-4971